Psoriasis in the elderly: From the Medical Board of the National Psoriasis Foundation

Journal of the American Academy of Dermatology

Volumn 65, Issue 3, 2011, Pages 537-545

  Grozdev, Ivan S ^a   Van Voorhees, Abby S ^b   Gottlieb, Alice B ^c   Hsu, Sylvia ^d   Lebwohl, Mark G ^e   Bebo Jr , Bruce F ^e   Korman, Neil J ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

algorithm; elderly; evidence; geriatric; management; psoriasis; therapy

Indexed keywords

ADALIMUMAB; ALEFACEPT; BENDROFLUMETHIAZIDE; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; ETRETIN; FUROSEMIDE; INDOMETACIN; METHOTREXATE; RETINOID; TAZAROTENE; USTEKINUMAB; VITAMIN D DERIVATIVE;

AGED; ALGORITHM; ARTICLE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; ELDERLY CARE; HUMAN; KIDNEY FUNCTION; MEDLINE; OPPORTUNISTIC INFECTION; PHARYNGITIS; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA; QUALITY OF LIFE; SKIN CARCINOMA; TOXIC EPIDERMAL NECROLYSIS; ULTRAVIOLET B RADIATION;

AGED; DERMATOLOGIC AGENTS; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; ULTRAVIOLET THERAPY;

EID: 80051781781     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.05.014     Document Type: Article

References (58)

1. L.M. Bell, R. Sedlack, C.M. Beard, H.O. Perry, C.J. Michet, and L.T. Kurland Incidence of psoriasis in Rochester, Minn, 1980-1983 Arch Dermatol 127 1991 1184 1187
2. Y.H. Liao, K.H. Chen, M.P. Tsenq, and C.C. Sun Pattern of skin diseases in a geriatric patient group in Taiwan: a 7-year survey from the outpatient clinic of a university medical center Dermatology 203 2001 308 313 (Pubitemid 34045192)
3. E.S. Smith, A.B. Fleischer Jr., and S.R. Feldman Demographics of aging and skin disease Clin Geriatr Med 17 2001 631 641 (Pubitemid 33032504)
4. Projected resident population of the United States as of July 1, 2025, middle series. Population Projections Program, Population Division, US Census Bureau, Washington, D.C. 20233, 2002.
5. Eurostat, 1999. Regional population ageing of the EU at different speeds up to 2025, Statistics in focus. In: Eurostat. 1999:1-8.
6. A.B. Gottlieb, and F. Dann Comorbidities in patients with psoriasis Am J Med 122 1150 2009 e1 e9
7. A. Gottlieb, N.J. Korman, K.B. Gordon, S.R. Feldman, M. Lebwohl, and J.Y. Koo Guidelines of care for the management of psoriasis and psoriatic arthritis: section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics J Am Acad Dermatol 58 2008 851 864 (Pubitemid 351509657)
8. D.D. Gladman, C. Antoni, P. Mease, D.O. Clegg, and P. Nash Psoriatic arthritis: epidemiology, clinical features, course, and outcome Ann Rheum Dis 64 Suppl 2005 ii14 ii17
9. J.M. Gelfand, D.D. Gladman, P.J. Mease, N. Smith, D.J. Margolis, and T. Nijsten Epidemiology of psoriatic arthritis in the population of the United States J Am Acad Dermatol 53 2005 573 577 (Pubitemid 41399922)
10. A.B. Kimball, D. Gladman, J.F. Gelfand, K. Gordon, E.J. Horn, and N.J. Korman National Psoriasis Foundation: clinical consensus on psoriasis comorbidities and recommendations for screening J Am Acad Dermatol 58 2008 1031 1042
11. A.D. Cohen, H. Gilutz, Y. Henkin, D. Zahger, J. Shapiro, and D.Y. Bonneh Psoriasis and the metabolic syndrome Acta Derm Venereol 87 2007 506 509 (Pubitemid 351373394)
12. P. Gisondi, G. Tessari, A. Conti, S. Piaserico, S. Schianchi, and A. Peserico Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study Br J Dermatol 157 2007 68 73 (Pubitemid 46934281)
13. Al Neimann, D.B. Shin, X. Wang, D.J. Margolis, A.B. Troxel, and J.M. Gelfand Prevalence of cardiovascular risk factor in patients with psoriasis J Am Acad Dermatol 55 2006 829 835 (Pubitemid 44556851)
14. Y.B. Brauchli, S.S. Jick, M. Miret, and C.R. Meier Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis J Invest Dermatol 129 2009 2604 2612
15. A. Wilczek, and M. Sticherling Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship? Int J Dermatol 45 2006 1353 1357 (Pubitemid 44688036)
16. G. Yosipovitch, and B.Y. Tang Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options Drugs Aging 19 2002 847 863 (Pubitemid 35440604)
17. J. Dreiher, D. Weitzman, and A.D. Cohen Psoriasis and osteoporosis: a sex-specific association? J Invest Dermatol 129 2009 1643 1649
18. A. Osmancevic, K. Landin-Wilhelmsen, O. Larko, D. Mellstrom, A.M. Wennberg, and L. Hulthen Risk factors for osteoporosis and bone status in postmenopausal women with psoriasis treated with UVB therapy Acta Derm Venereol 88 2008 240 246 (Pubitemid 351743866)
19. A.Y. Finlay, and E.C. Coles The effect of severe psoriasis on the quality of life of 369 patients Br J Dermatol 132 1995 236 244
20. D.G. Fortune, C.J. Main, T.M. O'Sullivan, and C.E. Griffiths Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress Br J Dermatol 137 1997 755 760 (Pubitemid 27496193)
21. S.R. Rapp, S.R. Feldman, M.L. Exum, A.B. Fleischer Jr., and D.M. Reboussin Psoriasis causes as much disability as other major medical diseases J Am Acad Dermatol 41 1999 401 407 (Pubitemid 29418506)
22. F. Sampogna, M.M. Chren, C.F. Melchi, P. Pasquini, S. Tabolli, and D. Abeni Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis Br J Dermatol 154 2006 325 331 (Pubitemid 43382705)
23. S.R. Feldman, A.B. Fleischer, D.M. Reboussin, S.R. Rapp, D.D. Bradham, and M.L. Exum The economic impact of psoriasis increases with psoriasis severity J Am Acad Dermatol 37 1997 564 569 (Pubitemid 27446725)
24. G.J. Nevitt, and P.E. Hutchinson Psoriasis in the community: prevalence, severity and patient's beliefs and attitudes towards the disease Br J Dermatol 135 1996 533 537 (Pubitemid 26340262)
25. M.D. Herron, M. Hinckley, M.S. Hoffman, J. Papenfuss, C.B. Hansen, and K.P. Callis Impact of obesity and smoking on psoriasis presentation and management Arch Dermatol 141 2005 1527 1534 (Pubitemid 41815842)
26. G. Yosipovitch, A. Goon, J. Wee, Y.H. Chan, and C.L. Goh The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis Br J Dermatol 143 2000 969 973
27. P.G. Shekelle, S.H. Woolf, M. Eccles, and J. Grimshaw Clinical guidelines: developing guidelines BMJ 318 1999 593 596
28. R. Parslew, and J. Trauslen Efficacy and local safety of a calcipotriol/betamethasone dipropionate ointment in elderly patients with psoriasis vulgaris Eur J Dermatol 15 2005 37 39 (Pubitemid 40254621)
29. A. Osmancevic, K. Landin-Wilhelmsen, O. Larko, D. Mellstrom, A.M. Wennberg, and L. Hulthen UVB therapy increases 25(OH) vitamin D syntheses in postmenopausal women with psoriasis Photodermatol Photoimmunol Photomed 23 2007 172 178 (Pubitemid 47354708)
30. G.M. Fairris, A.G. Dewhurst, J.E. White, and M.J. Campbell Methotrexate dosage in patients aged over 50 with psoriasis BMJ 298 1989 801 802 (Pubitemid 19084525)
31. P. Collins, and S. Rogers The efficacy of methotrexate in psoriasis-a review of 40 cases Clin Exp Dermatol 17 1992 257 260
32. A.B. Gottlieb, W.H. Boehncke, and M. Darif Safety and efficacy of alefacept in elderly and other special populations J Drugs Dermatol 4 2005 718 724
33. G. Militello, A. Xia, S.R. Stevens, and A.S. Van Voorhees Etanercept for the treatment of psoriasis in the elderly J Am Acad Dermatol 55 2006 517 519 (Pubitemid 44189579)
34. C. Bonifati, M. Carducci, A. Mussi, L. D'Auria, and F. Ameglio Recognition and treatment of psoriasis: special considerations in elderly patients Drugs Aging 12 1998 177 190 (Pubitemid 28130094)
35. A.G. Dawn, M.E. Dawn, and G. Yosipovich Psoriasis in the elderly Aging Health 3 2007 611 623 (Pubitemid 350055655)
36. R.J. Coskey Adverse effects of corticosteroids, I: topical and intralesional Clin Dermatol 4 1986 155 160
37. B.J. Montgomery Bathing for psoriasis in the Dead Sea J Am Med Assoc 241 1979 227 231
38. A.P. Kushelevsky, M. Harari, E. Hristakieva, and J. Shani Climatotherapy of psoriasis in elderly patients at the Dead Sea Pharmacol Res 34 1996 87 91 (Pubitemid 27016316)
39. J.W. Gould, M.G. Mercurio, and C.A. Elemets Cutaneous photosensitivity diseases induced by exogenous agents J Am Acad Dermatol 33 1995 551 573
40. R. Bressler, and J.J. Bahl Principles of drug therapy for the elderly patient Mayo Clin Proc 78 2003 1564 1577 (Pubitemid 37475642)
41. K. Turnheim Drug dosage in the elderly: is it rational? Drugs Aging 13 1998 357 379
42. A. Flamminger, and H. Maibach Drug dosage in the elderly: dermatological drugs Drugs Aging 23 2006 203 215
43. F. Bressolle, C. Bologna, J.M. Kinowski, B. Arcos, J. Sany, and B. Comb Total and free methotrexate pharmacokinetics in elderly patients with rheumatoid arthritis J Rheumatol 24 1997 1903 1909 (Pubitemid 27431920)
44. M. Boffa, and R. Chalmers Methotrexate for psoriasis Clin Exp Dermatol 21 1996 399 408 (Pubitemid 27198662)
45. W. Evans, and M. Christensen Drug interactions with methotrexate J Rheumatol 12 1985 15 20 (Pubitemid 16082374)
46. V.K. Ranganath, and D.E. Furst Disease-modifying antirheumatic drug use in elderly rheumatoid patients Rheum Dis Clin North Am 33 2007 197 217 (Pubitemid 46400364)
47. S. Prodanovich, F. Ma, J.R. Taylor, C. Pezon, T. Fasihi, and R.S. Kirsner Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis J Am Acad Dermatol 52 2005 262 267
48. P. Falck, A. Asberg, K.T. Byberrg, S. Bremer, S. Bergan, and J.L. Reubsaet Reduced elimination of cyclosporine A in elderly (65 years) kidney transplant recipients Transplantation 86 2008 1379 1383
49. M. Lebwohl, C. Ellis, A. Gottlieb, J. Koo, G. Krueger, and K. Linden Cyclosporine consensus conference: with emphasis on the treatment of psoriasis J Am Acad Dermatol 39 1998 464 475 (Pubitemid 28417385)
50. V.M. Heydendael, P.I. Spuls, I.J. Ten Berge, B.C. Opmeer, J.D. Bos, and M.A. de Rie Cyclosporine trough levels: is monitoring necessary during short-term treatment in psoriasis Br J Dermatol 147 2002 122 129
51. R. Fleischmann, S.W. Baumgartner, M.H. Weisman, T. Liu, B. White, and P. Peloso Long term safety of etanercept in elderly subjects with rheumatic diseases Ann Rheum Dis 65 2006 379 384 (Pubitemid 43268229)
52. A. Menter, K.B. Gordon, C.L. Leonardi, Y. Gu, and O.M. Goldblum Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis J Am Acad Dermatol 63 2010 448 456
53. Adalimumab [package insert]. Available from: URL: http://www.adalimumab. com/adalimumab/assets/HCP-PPI.pdf. Accessed April 1, 2010.
54. Infliximab [package insert]. Available from: URL: http://www.remicade. com/remicade/assets/HCP-PPI.pdf. Accessed April 1, 2010.
55. M. Govoni, and F. Trotta High incidence of serious adverse events among elderly rheumatoid arthritis patients receiving monoclonal anti-TNFα antibodies [abstract] Ann Rheum Dis 66 2007 181
56. Agaenevay Reasons for discontinuing TNF blockers: a Swiss RA registry study [abstract] Ann Rheum Dis 65 2006 430
57. J.E. McElhaney, and R.B. Effros Immunosenescence: what does it mean to health outcomes in older patients? Curr Opin Immunol 21 2009 418 424
58. M. Lebwohl, J. Bagel, J. Gelfand, D. Gladman, K.B. Gordon, and S. Hsu From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis J Am Acad Dermatol 58 2008 94 105 (Pubitemid 350302037)